India reports 24,700 maternal deaths per one lakh live births in 2023, global analysis finds

IMT News Desk
IMT News Desk
· 3 min read
India recorded 24,700 maternal deaths per one lakh live births in 2023, according to a global analysis that highlights persistent maternal health gaps despite worldwide progress.

India recorded 24,700 maternal deaths per one lakh live births in 2023, placing it among the countries in South Asia and sub-Saharan Africa with the highest maternal death burden, according to a new global analysis published in The Lancet Obstetrics, Gynaecology, and Women’s Health. The findings come as the world continues to make progress on maternal mortality, but not fast enough to meet global targets in many countries.

The study, led by researchers from the Institute for Health Metrics and Evaluation at the US’ University of Washington, along with global collaborators, said maternal deaths have declined over the past three decades, but the pace of improvement has slowed and remains uneven across regions. The Global Burden of Disease 2023 research provides the most up-to-date assessment of maternal mortality trends across 204 countries and territories through 2023.

The global picture shows both progress and persistent gaps. Researchers estimated that there were 2.4 lakh maternal deaths worldwide in 2023, equivalent to a global maternal mortality ratio of 190.5 maternal deaths per one lakh live births. That marks a decline of more than one-third from 321 maternal deaths per one lakh live births in 1990.

Even so, the report said 104 of 204 countries and territories have not yet met the Sustainable Development Goal target of fewer than 70 maternal deaths per one lakh live births. The authors said the remaining gap highlights the need for renewed action and sustained investment, especially with less than five years left to achieve the target.

India’s figure was higher than Pakistan’s, which was estimated at 10,300 maternal deaths per one lakh live births in 2023. Among the African countries cited in the analysis, Ethiopia recorded 11,900 maternal deaths per one lakh live births, while Nigeria had 32,900.

The study found that the leading causes of maternal deaths vary by location, but maternal haemorrhage and hypertensive disorders of pregnancy accounted for the largest share of deaths globally. Researchers said improved access to antenatal care, safe delivery services, emergency obstetric care and post-partum follow-up could substantially reduce mortality, particularly in countries with the highest burden.

The analysis also noted that COVID-19 contributed to higher maternal mortality early in the pandemic. Before widespread vaccination, during 2020 and 2021, COVID-19 caused temporary increases in maternal deaths in regions and locations with high COVID-19 mortality.

The findings add to concerns over the pace of progress in maternal health, even as the long-term trend points downward. Researchers said stronger health systems, better monitoring and continued investment will be critical to bringing down deaths further and improving outcomes for mothers worldwide.

Read Next

Terumo India signs MoU with AIG Hospitals to strengthen interventional radiology training
News
April 22, 2026

Terumo India signs MoU with AIG Hospitals to strengthen interventional radiology training

Terumo India has signed a Memorandum of Understanding (MoU) with AIG Hospitals to establish a Centre of Excellence for Interventional Radiology (IR) under its flagship ‘Elevate IR’ programme. This collaboration is designed to improve clinical outcomes, reduce procedural risks and expand access to advanced, minimally invasive treatments for a wide range of conditions, from vascular […]
Article by: IMT News Desk
Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US
News
April 22, 2026

Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US

Lupin Limited (Lupin) has announced the launch of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, 10 mg/1,000 mg in the United States following the approval for its Abbreviated New Drug Application from the U.S. FDA as bioequivalent to Xigduo® XR for the indications in the approved labeling.
Article by: IMT News Desk
Medicover Hospitals Recognised for Excellence in Advanced Stroke Care Services by QAI
News
April 22, 2026

Medicover Hospitals Recognised for Excellence in Advanced Stroke Care Services by QAI

Medicover Hospitals, Kharghar, has earned QAI accreditation for its Advanced Stroke Centre, marking a major milestone in its commitment to delivering high-quality stroke care. This recognition validates that the hospital’s advanced stroke care services are aligned with international benchmarks. The hospital has established a robust system involving rapid triage, advanced imaging, acute care pathways, a […]
Article by: IMT News Desk
Ayush Dept Representatives Mandated in State Panels for Bio-Medical Waste Management
News
April 22, 2026

Ayush Dept Representatives Mandated in State Panels for Bio-Medical Waste Management

The Union Ministry of Environment, Forest and Climate Change has amended the Bio-Medical Waste Management Rules, 2016, to mandate the inclusion of Department of Ayush representatives in state and Union Territory advisory committees overseeing rule implementation. A separate amendment requires a nominated Ayush department representative in district-level monitoring committees to ensure compliance across healthcare facilities […]
Article by: IMT News Desk